|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Postlicensure safety smweillance for quadrivalent human papillomavirus recombinant vaccine显示文摘 | Slade BA l eidel L Vellozzi C | 2009 | JAMA2009，302，7： | 1 |
| 2 | Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine 显示文摘 | Slade BA Leidel L Vellozzi C | 2009 | JAMA2009，302，7： | 1 |
| 3 | Safety of trivalent inactivated influenza vaccines in adults:background for pandemic influenza vaccine safety monitoring显示文摘 | Vellozzi C Burwen DR Dobardzic A | 2009 | Vaccine2009，27，15： | 1 |
| 4 | Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine 显示文摘 | Slade BA Leidel L Vellozzi C | 2009 | JAMA2009，302，7： | 1 |
| 5 | Adverse events following influenza A (H1N1)2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United State, October 1, 2009 -January 31,2010显示文摘 | Vellozzi C Broder KR Haber P | 2010 | Vaccine2010，28，45： | 1 |
| 6 | Guillain-Barre syndrome, Influenza vaccination, and antecedent respiratory and gastrointestinal infections: a case-centered analysis in the vaccine safety datalink, 2009-2011显示文摘 | Greene SK Rett MD Vellozzi C | 2013 | PLoS One2013，8，67： | 1 |
| 7 | Gust response factors显示文摘 | Vellozzi J Edward C | 1968 | Journal of the structural division1968，94，6： | 1 |
| 8 | Safety of trivalent inactivated influenza vaccines in adults:background for pandemic influenza vaccine safety monitoring显示文摘 | Vellozzi C Burwen DR Dobardzic A | 2009 | Vaccine2009，27，15： | 1 |
| 9 | Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine 显示文摘 | Slade BA Leidel L Vellozzi C | 2009 | JAMA2009，302，7： | 1 |
| 10 | Causality assessment of serious neurologic adverse events following 2009 HIN1 vaccination显示文摘 | Williams S E Pahud B A Vellozzi C | 2009 | Vaccine2009，29，46： | 1 |
| 11 | Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine显示文摘 | Slade B A Leidel L Vellozzi C | 2009 | JAMA2009，302，7： | 1 |
| 12 | Safety of Influenza A ( H1N1 ) 2009 Monovalent Vaccines-United States, October 1-No- vember 24, 2009 显示文摘 | Broder K Vellozzi C Weinbaum C | 2009 | MMWR Morb Mortal Wkly Rep2009，58，48： | 1 |
| 13 | Global burden of neural tube defects, risk factors, and prevention 显示文摘 | FLORES AL VELLOZZI C VALENCIA D | 2014 | Indian J Community Health2014，26，1： | 1 |
| 14 | Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring 显示文摘 | VELLOZZI C BURWEN D R DOBARDZIC A et ol | 2009 | Vaccine2009，27，15： | 1 |
| 15 | Adverse events follow- ing influenza A(H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010 显示文摘 | Vellozzi C Broder' KR Haber P etal | 2010 | Vaccine2010，28，45： | 1 |
| 16 | Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring 显示文摘 | Vellozzi C Burwen DR Dobardzic A | 2009 | Vaccine2009，27，15： | 1 |
| 17 | Surveillance guidelines for smallpox vaccine(vaccinia) adverse reactions显示文摘 | Casey C Vellozzi C Mootrey GT | 2006 | MMWR Recomm Rep2006，55，1： | 1 |
| 18 | Guillain-Barr6 Syndrome, In- fluenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections:A Case-Centered Analysis in the Vaccine Safety Datal- ink,2009 - 2011 显示文摘 | Greene SK Rett MD Vellozzi C | 2013 | PLoS One2013，8，67： | 1 |
| 19 | Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the vaccine adverse event reporting System,United States,October 1,2009-January 31,2010显示文摘 | Vellozzi C Broder KR Haber P | 2010 | Vaccine2010，28，45： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员